Trial Profile
Phase III Randomized Trial of Gadolinium Texaphyrin (PCI-0120) Injection as a Radiation Sensitizer in Patients Receiving Whole Brain Radiation Therapy for the Treatment of Brain Metastases
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Motexafin gadolinium (Primary)
- Indications Brain metastases; Cancer metastases; Solid tumours
- Focus Registrational; Therapeutic Use
- Sponsors Pharmacyclics
- 25 Sep 2005 New trial record.